Correlation Engine 2.0
Clear Search sequence regions


  • adult (8)
  • case control studies (1)
  • cell (2)
  • child (1)
  • child preschool (1)
  • children (2)
  • chromosome (1)
  • diagnosis (2)
  • female (1)
  • gene (3)
  • humans (2)
  • infant (1)
  • leukemia (8)
  • male (1)
  • marrow (2)
  • miR 10 (1)
  • miR 146a (1)
  • miR 16 (1)
  • miR 17- 92 (2)
  • miR 181a (1)
  • miR 222 (1)
  • miR 223 (1)
  • miR 33 (1)
  • MIRN18 (1)
  • mirnas (3)
  • mirnas (5)
  • patients (5)
  • rna (4)
  • Sizes of these terms reflect their relevance to your search.

    Acute lymphoblastic leukemia (ALL) occurs in both adults and children but the response to chemotherapy and survival is significantly worse in the adults. We aimed to study whether the expression of immune system-associated miRNAs would differ between adult and pediatric patients with ALL at the time of diagnosis. Inflammation-associated miRNA analysis was performed in 19 adults and 79 pediatric patients with ALL and involved miR-10, miR-15, miR-16, miR-17-92 cluster, miR-33, miR-146a, miR-150, miR-155, miR-181a, miR-222, miR-223, and miR-339. MiRNAs were first analyzed by miRNA microarray and thereafter validated by qRT-PCR. Sufficient RNA for qRT-PCR was available for 42 pediatric and 19 adult patients. Of the studied miRNAs, only miR-18a differed significantly in microarray analysis between adult and pediatric ALL, being lower in children (FC, -3.74; P, 0.0037). Results were confirmed by qRT-PCR (down-regulated in pediatric patients, P 0.003161). The other members of the miR-17-92 cluster did not differ significantly. Pediatric and adult patients with ALL have remarkably similar patterns of immune-cell-associated miRNAs in their bone marrow at diagnosis. However, the low expression of miR-18a in pediatric ALL is interesting and demands further study.

    Citation

    Neda Mosakhani, Mohamed El Missiry, Emmi Vakkila, Sakari Knuutila, Jukka Vakkila. Low Expression of miR-18a as a Characteristic of Pediatric Acute Lymphoblastic Leukemia. Journal of pediatric hematology/oncology. 2017 Nov;39(8):585-588

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 29068867

    View Full Text